Amgen's research and development facility in San Francisco. (courtesy photo) Biotech giant Amgen is being sued by four healthcare providers, including the largest Medicaid provider in the country, for allegedly unlawfully excluding competition for its drug Enbrel. Also named as a defendant in the July 29 lawsuit is Immunex, a biotech company that Thousand Oaks-based…
This article is only available to Business Times subscribers
Subscribers: LOG IN or REGISTER for complete digital access.
Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
